17.05.2011 • NewsgenericsPharmaShlomo Yanai

Teva CEO Shlomo Yanai Says Always Looking for More Acquisitions

Teva CEO Shlomo Yanai
Teva CEO Shlomo Yanai

Teva Pharmaceutical Industries is always looking for acquisitions and will move on other potential targets when it finds a strategic fit, its top executive said on Monday.

"We are scrutinizing constantly the opportunities and in due time we will move for further acquisitions when we find them a ... strategic fit," Teva CEO Shlomo Yanai said at a briefing in Tokyo.

Teva said on Monday that it would acquire 57% of privately held Taiyo Pharmaceutical Industry for $460 million in cash and would make an offer to buy the remaining shares of Japan's third-largest generic pharmaceutical company.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.